Literature DB >> 15227391

Use of absorbable sutures in canine carotid arteries.

A R Rey1, J Carrillo-Farga, C O Velasco, M O Valencia.   

Abstract

To study the functional and microstructural characteristics of polydioxanone sutures in vascular surgery, we created 48 vascular anastomoses in the right and left common carotid arteries of 24 mongrel dogs. In each animal, polydioxanone sutures were used in 1 carotid artery, and polypropylene sutures were used in the contralateral carotid artery. Twelve groups of 2 animals each were then formed. The 1st group was observed for 1 month, the 2nd for 2 months, the 3rd for 3 months, and so on until the 12th group, which was observed for 12 months. At the end of each observation period, reoperation was undertaken to evaluate the vascular anastomoses by means of angiography and microscopy. The polypropylene anastomoses showed a marked deformity, with tissue retraction and a foreign body reaction. In contrast, the polydioxanone anastomoses exhibited satisfactory healing, without deformity, and were well tolerated histologically. We believe that polydioxanone may be a useful, alternative vascular suture material.

Entities:  

Year:  1990        PMID: 15227391      PMCID: PMC326462     

Source DB:  PubMed          Journal:  Tex Heart Inst J        ISSN: 0730-2347


  29 in total

1.  The growth of the normal aorta and of the anastomotic site in infants following surgical resection of coarctation of the aorta.

Authors:  A J MOSS; F H ADAMS; B J O'LOUGHLIN; W J DIXON
Journal:  Circulation       Date:  1959-03       Impact factor: 29.690

2.  Repair of growing vessels. Continuous absorbable or interrupted nonabsorbable suture?

Authors:  R M Stillman; Z Sophie
Journal:  Arch Surg       Date:  1985-11

3.  A biologic comparison of polyglactin 910 and polyglycolic acid synthetic absorbable sutures.

Authors:  P H Craig; J A Williams; K W Davis; A D Magoun; A J Levy; S Bogdansky; J P Jones
Journal:  Surg Gynecol Obstet       Date:  1975-07

4.  Cardiopulmonary bypass in infants under four months of age.

Authors:  S Sugimura; A Starr
Journal:  J Thorac Cardiovasc Surg       Date:  1977-06       Impact factor: 5.209

5.  PDS (polydioxanone suture): a new synthetic absorbable suture in cataract surgery. A preliminary study.

Authors:  R S Bartholomew
Journal:  Ophthalmologica       Date:  1981       Impact factor: 3.250

6.  Vascular anastomoses in growing vessels: the use of absorbable sutures.

Authors:  J L Myers; J A Waldhausen; W E Pae; A B Abt; G A Prophet; W S Pierce
Journal:  Ann Thorac Surg       Date:  1982-11       Impact factor: 4.330

7.  Anatomic correction of transposition of the great vessels.

Authors:  A D Jatene; V F Fontes; P P Paulista; L C Souza; F Neger; M Galantier; J E Sousa
Journal:  J Thorac Cardiovasc Surg       Date:  1976-09       Impact factor: 5.209

8.  Early onset of pulmonary vascular obstruction in patients with aortopulmonary transposition and intact ventricular septum.

Authors:  J B Lakier; P Stanger; M A Heymann; J I HoffmaN; A M Rudolph
Journal:  Circulation       Date:  1975-05       Impact factor: 29.690

9.  A new synthetic monofilament absorbable suture made from polytrimethylene carbonate.

Authors:  A R Katz; D P Mukherjee; A L Kaganov; S Gordon
Journal:  Surg Gynecol Obstet       Date:  1985-09

10.  Polydioxanone suture material in growing vascular anastomoses. Experimental study.

Authors:  I Verschuere; K Francois; J De Roose; G Berzsenyi; F Derom
Journal:  J Thorac Cardiovasc Surg       Date:  1985-11       Impact factor: 5.209

View more
  2 in total

1.  Selective two-stage basilic and cephalic vein transpositions can significantly improve the rate of fistula construction.

Authors:  Homayoun Hashemi; Michael J Sheridan; Beverly Ford
Journal:  Int J Angiol       Date:  2009

2.  Results of an observational study in carotid surgery using absorbable suture material.

Authors:  Marko Aleksic; Jan Uedelhoven; Vladimir Matoussevitch; Thomas Luebke; Salvatore Tomagra; Barbara Krug; Jan Brunkwall
Journal:  World J Surg       Date:  2009-01       Impact factor: 3.352

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.